HCPCS Level IIdrugActive
J8611
Oral methotrexate (jylamvo)
BETOS: O1D
Effective: 2024-07-01
Description
Methotrexate (jylamvo), oral, 2.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Jylamvo
Manufacturer
Shorla Oncology Inc.
HCPCS Dosage
2.5 MG
Billing Units
48.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.